Search Results - "Boronow, John"
-
1
Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status
Published in Psychiatry research (30-11-2004)“…Cognitive dysfunction is an important feature of schizophrenia and bipolar disorder. There is uncertainty about the relative magnitude of cognitive deficits in…”
Get full text
Journal Article -
2
Association Between Cognitive Functioning and Employment Status of Persons With Bipolar Disorder
Published in Psychiatric services (Washington, D.C.) (01-01-2004)“…OBJECTIVE: The purpose of this study was to identify variables associated with employment status among persons with bipolar disorder, including cognitive…”
Get full text
Journal Article -
3
Predictors of occupational status six months after hospitalization in persons with a recent onset of psychosis
Published in Psychiatry research (30-09-2008)“…Abstract Participation in work or school activity is an important aspect of social functioning in individuals with a recent onset of psychosis. We measured the…”
Get full text
Journal Article -
4
Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder
Published in Biological psychiatry (1969) (15-03-2004)“…In a previous investigation, we found an association between reduced cognitive functioning and the prevalence of antibodies to herpes simplex virus type 1 in…”
Get full text
Journal Article -
5
A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii
Published in Schizophrenia research (01-07-2009)Get full text
Journal Article -
6
Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up
Published in Schizophrenia research (04-05-1999)“…Neurocognitive deficits have been associated with the social functioning impairments of patients with schizophrenia. More information is needed about how…”
Get full text
Journal Article -
7
Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus
Published in Schizophrenia research (01-02-2009)“…Abstract Objective To investigate if adjunctive valacyclovir, an antiviral medication, reduces symptoms of persistent schizophrenia in individuals who are…”
Get full text
Journal Article -
8
The Association Between Cognitive Functioning and Occupational Status in Persons With a Recent Onset of Psychosis
Published in The journal of nervous and mental disease (01-07-2007)“…The ability to engage in occupational activity is an important aspect of functioning in individuals with recent onset psychosis. We measured the determinants…”
Get full text
Journal Article -
9
The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder
Published in Bipolar disorders (01-04-2006)“…Background: Bipolar disorder is associated with deficits in cognitive functioning. The etiology of cognitive impairment in bipolar disorder may relate to both…”
Get full text
Journal Article -
10
Reduction of Symptoms by Valacyclovir in Cytomegalovirus-Seropositive Individuals With Schizophrenia
Published in The American journal of psychiatry (01-12-2003)“…OBJECTIVE: The study was an investigation of the effect of the antiviral medication valacyclovir on the symptoms of outpatients with persistent schizophrenia…”
Get full text
Journal Article -
11
Difficult Psychiatric Consultations: An Integrated Approach
Published in Psychiatric services (Washington, D.C.) (01-05-2015)Get full text
Journal Article -
12
The catechol O -methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia
Published in Schizophrenia research (01-11-2007)“…Abstract Background A valine/methionine polymorphism of the catechol O -methyltransferase gene at the nucleotide which encodes amino acid val or met at…”
Get full text
Journal Article -
13
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia
Published in Schizophrenia research (01-07-2007)“…Abstract Objectives We investigated the association between serum levels of C-reactive protein (CRP), a marker of inflammation, and the severity of…”
Get full text
Journal Article -
14
Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder
Published in Progress in neuro-psychopharmacology & biological psychiatry (09-05-2007)“…We investigated the association between serum levels of C-reactive protein (CRP), a marker of inflammation, and the severity of psychopathology in outpatients…”
Get full text
Journal Article -
15
Ensuring Staff Safety When Treating Potentially Violent Patients
Published in JAMA : the journal of the American Medical Association (27-12-2016)“…Workplace violence in health care settings is worsening. In a recent report from The Joint Commission noted that the incidence had increased from 2.0…”
Get full text
Journal Article -
16
Placebo response in a double-blind therapeutic supplementation trial in stabilized outpatients with schizophrenia
Published in Schizophrenia research (2003)Get full text
Journal Article -
17
Managed care and clinical reality in schizophrenia treatment
Published in Health affairs (Millwood, Va.) (01-09-1999)“…Managed care, which now dominates the changes that are taking place in the organization of services for people with serious mental illness, is only the most…”
Get full text
Journal Article -
18
Association of Serum Antibodies to Herpes Simplex Virus 1 With Cognitive Deficits in Individuals With Schizophrenia
Published in Archives of general psychiatry (01-05-2003)“…BACKGROUND Cognitive deficits are a characteristic feature of schizophrenia and contribute to the profound disabilities associated with this illness. Some of…”
Get full text
Journal Article -
19
Toxoplasma gondii in Individuals With Schizophrenia: Association With Clinical and Demographic Factors and With Mortality
Published in Schizophrenia bulletin (01-05-2007)“…Background: Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia as compared with control groups, but the…”
Get full text
Journal Article -
20
Dextro-amphetamine diminishes negative symptoms in schizophrenia
Published in International clinical psychopharmacology (01-04-1988)“…Thirty schizophrenic patients received intravenous dextro-amphetamine while on and off pimozide. The results provide evidence that negative symptoms and…”
Get more information
Journal Article